SNDX

Syndax Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 3/10
  • Momentum↑ 7/10
Syndax Pharmaceuticals sales and earnings growth
SNDX Growth
Neutral
  • Revenue Y/Y↑ 597.19%
  • EPS Y/Y↓ 1.10%
  • FCF Y/Y↓ -20.14%
Syndax Pharmaceuticals gross and profit margin trends
SNDX Profitability
Neutral
  • Gross margin ↑ 95.40%
  • EPS margin↓ -279.30%
  • ROIC↓ -38.50%
Syndax Pharmaceuticals net debt vs free cash flow
SNDX Risk
Fair
  • Debt / Equity↑ 3.0
  • Debt / FCF↓ 0.7
  • Interest coverage↓ -9.7

Syndax Pharmaceuticals stock volatility is in-line with the overall market. We give it a Fair risk rating.

More Biotechnology stocks ↗